SUBSCribe
logo
twitterlinkedininstagramUser Profile
  • BIG STORY
  • PERSPECTIVE
    • Editor's Note
  • ENTERPRISE
    • STRATEGY
      • HIGH FIVE
      • AD Break
    • MARKETS
      • PIXTORY
        • SPECIALS
        • VIDEOS
        • WOMEN
        • C’est La Vie
          • My Favourite
          • Pursuit of Happiness
          • The Good Life
          • Hardbound
        • MAGAZINE
        • EVENTS
          • LEADING EDGE
          • SMART ENTERPRISE
        • New growth formula

          The US market remains choppy but Natco Pharma is becoming a compelling bet by rebooting itself with a new strategy

          Prathamesh Mulye - November 04, 2019
        • The Outperformers (51-60)

          These companies have been ranked based on their stock's excess return over the Sensex for a five-year period

          September 03, 2019
        • Cherry-Picking Fallen Angels — Part 2

          Here is a list of stocks that have fallen in the small and mid-cap carnage despite reporting robust numbers

          Prathamesh Mulye - July 19, 2018
        • Ajay Relan

          His bet on Natco Pharma’s differentiated product portfolio paid off while Monnet Ispat taught him to be wary of over-ambitious entrepreneurs

          Krishna Gopalan - September 18, 2017
        • Self-healing

          Hyderabad’s pharma players are adapting to a regulatory backlash and fighting back against dumping from China

          Krishna Gopalan - March 09, 2016

        Latest Edition

        magcover
        January 29, 2021
        magcover
        January 15, 2021
        magcover
        January 1, 2021
        magcover
        December 18, 2020
        twitterlinkedininstagramUser Profile
        • BIG STORY
        • PERSPECTIVE
        • ENTERPRISE
        • STRATEGY
        • MARKETS
        • PIXTORY
        • SPECIALS
        • VIDEOS
        • WOMEN
        • C'EST LA VIE
        • MAGAZINE
        About us Contact usPrivacy PolicyTerms and ConditionsSitemap
        Copyright © 2019 Outlook Business!. All pages of the Website are subject to our terms and conditions and privacy policy. You must not reproduce, duplicate, copy, sell, resell or exploit any material on the Website for any commercial purposes.